-
GSK knew about Zantac cancer risk, attorneys tell jury in first trial
Valadez's case is one of tens of thousands against GSK, Boehringer Ingelheim and other pharmaceutical companies, which have worried investors in recent years. It will offer the first test of whether the cancer claims in the long-running litigation will persuade a jury, since all cases previously set for trial settled or were dropped.
-
India premier destination for conducting global clinical trials, says Harvard scholar
-
AstraZeneca vaccine side effect rare, occurs within a month of getting jab: Ex-ICMR Scientist
-
Almost 43 pc health insurance policyholders struggled to get claims processed in last 3 yrs: Survey
-
ETPharma to host inaugural edition of ETPharma Clinical Research Excellence Conference
Advertisement
Hospitals
Advertisement
